IPWatchdog and CAS offer a joint webinar: Best Practices in High-Stakes IP Searches for M&A, Licensing, and Validity
Tuesday, October 27, 2020 at 12 pm ET | 5 pm CET | 9:30 PM IST
Registration Link
Companies are using product licensing, patent transactions, mergers and acquisitions to build patent portfolios for various reasons and as part of new growth strategies. But searching in the life sciences and biochemical technology areas is extraordinarily complex and projects require multiple people to be aligned on goals and strategies.
Searching advances in chemistry and related sciences requires human intelligence and a wealth of specialized knowledge. The key insights such searching can provide is a critically important part of due diligence for any high-stakes deals.
While there is a need to preserve capital and cut costs, to the greatest extent reasonably possible, success in these initiatives is of paramount importance.
This panel will share insights on successfully navigating IP-driven, high-stakes business transactions, and how to ensure your teams have the right information for success.
Speakers: Heidi Berven, Ph.D., Partner & Co-leader, Patent Practice Group, Honigman; Paul Coletti, Associate Patent Counsel, Johnson & Johnson; Matthew McBride, Director of IP Search, CAS, Gene Quinn, President, CEO & Founder, IPWatchdog, Inc.
https://www.facebook.com/CAS/photos/a.135720653139795/3861244093920747/?type=3&theater
Information about speakers
HEIDI BERVEN Ph.D., is a partner at Honigman and co-leader of the Patent practice group at the firm. She is a seasoned attorney with more than 20 years of experience. As patent counsel for both large and small companies, she honed her skills in drafting and prosecuting chemistry and pharmaceutical patent applications and in providing IP support for negotiations ranging from single-compound licensing transactions to whole company acquisitions. Dr. Berven’s practice routinely includes patent preparation and prosecution in the U.S. and globally; life cycle management of global patent portfolios; competitor intelligence; IP support for licensing negotiations; freedom-to-operate and patentability reviews; Patent Term Adjustment maximization by action before the USPTO and federal courts; and Orange Book listings and Patent Term Extension maximization for approved drug products…
PAUL COLETTI has been an Associate Patent Counsel of Johnson & Johnson since 1987, and has overall patent responsibility for Johnson & Johnson Medical Devices companies. His practice extends over all fields of patent law, including prosecution, litigation and client counseling. Paul is active in various patent and industry organizations, such as the U.S. Chamber of Commerce, IPO, AIPLA and AdvaMed, and serves on the EPO-US Bar Liaison Committee, for which he is a past Chair. He has a B.S. in Mechanical Engineering (1980) from Polytechnic Institute of New York (now part of NYU); an M.S.(1981), in Mechanical Engineering from Purdue University; and a J.D.(1985) from the University of Notre Dame. Prior to joining Johnson & Johnson, Paul was an associate in a patent boutique in Chicago, and worked as an engineer for Bell Laboratories.
MATTHEW MCBRIDE is Director IP Search at CAS, where he manages all aspects of IP service development and sales and works regularly with CAS customers to develop effective strategies for delivering high-quality IP and scientific information. He became a member of the IP Services team in 2010, after spending six years as a Senior Application Specialist providing technical training for the STN and SciFinder software platforms to CAS customers. He holds a Master of Science degree in plant pathology from the University of Minnesota and a Bachelor of Science degree in molecular biology from Purdue University. In addition to his research experience at CAS, Matthew was an information consultant with Thomson Reuters and a biologist at Rohm and Haas. Matthew is a member of the Patent Information Users Group (PIUG) and the American Chemical Society (ACS).
GENE QUINN is a US Patent Attorney, the founder of IPWatchdog.com and a Top 300 IP Strategist. Gene writes about patent law, patent and innovation policy, proposed legislation, rulemaking, software patents and more. In 2014, Mr. Quinn was named one of the top 50 most influential people in IP by Managing IP Magazine. And in both 2017 and 2018, he has been recognized by IAM Magazine as one of the top IP strategists in the world. Regarded as an expert on software patentability and U.S. patent procedure, Mr. Quinn regularly advises attorneys and clients on patent matters, litigation strategy and appeals.
http://ipwatchdog-5753777.hs-sites.com/cas-ip-searches-october-27-2020
CAS Science IP: Types of Custom Searches & Meet the Science IP Team
Search
Community
Job Board
